Results 211 to 220 of about 2,049,823 (284)

Ocular Lesions Related to COVID-19 and Its Vaccines. [PDF]

J Ophthalmol
Liu T, Li M, Zhu L, Liang R, Zhang P, Liu X.   +5 more
europepmc   +1 more source

Synthetic Lethal Therapy Based on Dimorphism for Systemic Infection of Drug‐Resistant Candida albicans

Advanced Science, EarlyView.
To tackle the alarming mortality rate linked to Candida albicans infections, a synthetic lethal strategy precisely aimed at the two distinct forms of this fungus: yeast and hyphae is formulated. Ultimately, through the innovative use of macrophage membranes for drug delivery, the effectiveness of this strategy is substantially boosted while ...
Yang Gao, Jiahe Su, Jiawei Yuan, Qinyan Cao, Yue Wu, Yuyang Xiao, Guang Yang, Ruomu Xia, Jingpeng Yang, Yanan Li, Lina Wu, He Huang, Lingtong Meng   +12 more
wiley   +1 more source

Profiles of PCSK9, SREBP-2, and histopathology in COVID-19 and non-COVID-19 critical illness. [PDF]

BMC Infect Dis
Weber F, Pavel V, Müller M, Boor P, Läber L, von Stillfried S, Buechler C.   +6 more
europepmc   +1 more source

COVID 19 uncertainty [PDF]

Health Care for Women International, 2020
openaire   +2 more sources

Effectiveness of Pre‐Transplant Dual GLP‐1 Receptor Agonist and SGLT2 Inhibitor Therapy on All‐Cause Mortality in Organ Transplantation Candidates with Obesity and Type 2 Diabetes: a Target‐Trial Emulation

Advanced Science, EarlyView.
This target trial emulation in solid organ transplant candidates with obesity and type 2 diabetes evaluates whether pre‐transplant dual therapy with GLP‐1 receptor agonists plus SGLT2 inhibitors is associated with post‐transplant mortality and kidney graft outcomes compared with monotherapy or usual care, using multinational electronic health records ...
Yu‐Nan Huang, Min‐Yu Tsou, Pin‐Hung Li, Jo‐Ching Chen, Yen‐Liang Liu, Gideon Meyerowitz‐Katz, Tsung‐Hsun Tsai, Pen‐Hua Su   +7 more
wiley   +1 more source

Persistent COVID-19 Pneumonia in a Patient on Rituximab. [PDF]

J Investig Med High Impact Case Rep
Clarke K, Naidu S, Wan C, Stampfer S.
europepmc   +1 more source

CD147/Basigin: From Integrative Molecular Hub to Translational Therapeutic Target

Advanced Science, EarlyView.
This review conceptualizes CD147 as a fundamental “Energy‐Structure Coupler,” physically bridging metabolic flux (via MCTs) with morphogenetic plasticity (via integrins/MMPs) to drive cancer, infection, and autoimmunity. Addressing the “specificity paradox” that limits current translation, the authors chart a strategic roadmap—spanning logic‐gated ...
Xiang‐Min Yang, Huijie Bian, Zhi‐Nan Chen   +2 more
wiley   +1 more source

Does Home COVID-19 Testing Bias COVID-19 Vaccine Effectiveness Estimates? [PDF]

Am J Prev Med
Nowalk MP, Balasubramani GK, D'Agostino H, Zimmerman RK, Monto AS, Martin ET, Nguyen HQ, Gaglani M, Mamawala M, Tartof S, Lewin BJ, Wernli K, Wickersham B, Talbot HK, Grijalva CG, Chung JR, Flannery B, U.S. Flu VE Network Investigators.   +17 more
europepmc   +1 more source

Nanozymes Integrated Biochips Toward Smart Detection System

Advanced Science, EarlyView.
This review systematically outlines the integration of nanozymes, biochips, and artificial intelligence (AI) for intelligent biosensing. It details how their convergence enhances signal amplification, enables portable detection, and improves data interpretation.
Dongyu Chen, Wang Zheng, Zhihui Zhang, Shenping Yu, Xinxin Hang, Han Wu, Xiao‐Wei Xiang, Wei Mu, Yanli Jiao, Zaizai Dong, Lingqian Chang   +10 more
wiley   +1 more source

Cognitive consequences of COVID-19 infection: current evidence and future directions. [PDF]

World Psychiatry
Hampshire A.
europepmc   +1 more source